FDA Strategy For Functional Food Safety And Claims Needed, CSPI Urges
• By The Tan Sheet
FDA should take action to ensure "functional food" products are safe and bear truthful labeling claims, the Center for Science in the Public Interest asserts in a March 25 letter to FDA Commissioner Jane Henney, MD, and in an accompanying report entitled "Functional Foods - Public Health Boon or 21st Century Quackery."
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The UK regulator wants to help companies to develop bacteriophages for the treatment of infections. Its first guidance on this topic offers advice to researchers and sets out the regulatory requirements they will need to meet.